Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells: Journal of Neurochemistry
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells: Journal of Neurochemistry'. Together they form a unique fingerprint.